Destiny Pharma Share Discussion Threads

[captain james t kirk] 31/1/2024 12:42

In this vein this post from the other board:

"With respect, what more did you need explaining.

XF-73 passed the NIAID study with flying colours and can now advance to clinical evaluation for the treatment of Diabetic Foot infections and serious burn wound infections. The XF-73 platform continues to move forward.

As we were reminded, they flagged up possible changes to the Chemistry, Manufacturing and Controls programme for NTCD-M3 in the interims statement in September and this has now become a reality, resulting in an improved product.

There's obviously much going on behind the scenes and the new management team are not going to release any information to market which might compromise on going discussions on XF-73 nasal.

I personally do not have a problem with that, confident that the board is working to get the very best deal for the Company's shareholders, in seeking partners for this ground breaking new class of medicines."

[marvelman] 31/1/2024 12:33

"It’s all about XF-73 Nasal for post surgical infections"...Exactly so Adorling

[adorling] 31/1/2024 12:29

It’s all about XF-73 Nasal for post surgical infections as it targets a $10 billion US market alone. This lead product is not mentioned in this clinical RNS update for XF-Dermal.

Significant deal on XF-73 Nasal is the RNS that will multi-bag the share price when signed and announced. They don’t comment on it because they are probably deep in negotiations with big Pharma Co.

[arab3] 31/1/2024 11:26

Great to know marvelman , we will all sleep tonight

[marvelman] 31/1/2024 11:06

I don't normally trade but did so today after that inconclusive RNS. Bought back in now waiting for the important one which could come at any time

[john henry] 31/1/2024 08:51

Dr Bill Love, Chief Scientific Officer of Destiny Pharma said: "I would like to thank NIAID for their support and collaboration throughout the preclinical safety study in XF-73 Dermal and I am delighted to announce this positive dataset.

Dataset ?????

[john henry] 31/1/2024 08:40

I agree with you Banshee

[carlisle44] 31/1/2024 08:35

I liked it and added.

[banshee] 31/1/2024 08:30

They should have referenced the earlier XF dermal results in this RNS, to the casual reader it might seem they are saying xf-73 is safe but has no clinical impact. As with the business update in early Jan, this could have been better written. It should not impact on any XF-73 deal though,

[john henry] 31/1/2024 08:26

Just goes to show the craziness of AIM.

Destiny product portfolio grows ever stronger and investors take the MKT CAP down 10%

[john henry] 31/1/2024 08:15

Not sure what the market was expecting ?
The trial results data where announced in July 23
Today was the extended safety profile to take Dermal into the clinic.
10 k seller is throwing the kitchen sick at it

[banshee] 31/1/2024 08:13

Seems obvious to speculate that the formulation issue with m3 was identifed during partnership talks and accounts for the unusual structuring of that deal, specificaly the low upfront payment. I can't see their being any significant technical issues around reformulation, but the need for it does not speak well about the profesionalism of the previous mgmt imo.

[marvelman] 31/1/2024 08:12

Sold for now

[henley2] 31/1/2024 07:56

Delay to clinical trials and no mention of any progress on signing XF73 licensing deal.
Great start to 2024!

[banshee] 31/1/2024 07:50

Update is a mixed bag, decent on Xf-73, but potential 18 months+ delay on m3 looks a bit shambolic.

[john henry] 31/1/2024 07:47

Great update, XF73 into clinical trials

DFI is a massive problem.

[john henry] 29/1/2024 15:33

Personally i wouldnt have used the word imminent unless the report was in my hand.

[jeanesy] 29/1/2024 15:09

quite a few buys this afternoon but price not moving up

[brooko19] 29/1/2024 15:07

I get some peoples frustration of the word imminently being used however delays happen out of their control, I don’t think the market is really punishing them I just think there has been a seller for weeks and they are still selling whilst buying has dried up for now just need the first bit of news and then buys will return

[jeanesy] 29/1/2024 12:44

sadly the silence is becoming deafening here '' shouldn't use the word imminently when 3 weeks later nothing has been forthcoming !

[marvelman] 29/1/2024 11:02

"Destiny's priority remains to realise the maximum value for our XF-73 Nasal asset. The Company is evaluating all options to achieve this, including continuing discussions with a number of potential partners, with a view to delivering the best deal to maximise shareholder value. We will provide a further update in due course"

[marvelman] 29/1/2024 10:59

A reminder to sellers..RNS 4th January..."Pre-clinical results are expected imminently for XF-73 Dermal"

[xcap1] 24/1/2024 10:36

lol hope not

[xcap1] 24/1/2024 10:11

Agree, but I really do think the first rns is days away